Effect of percutaneous coronary intervention on quality of life: A consensus statement from the society for cardiovascular angiography and interventions

Percutaneous coronary intervention (PCI) decreases ischemic complications of acute coronary syndromes. The benefits of PCI in stable ischemic heart disease (SIHD) depend on its effect on quality of life (QoL), including angina, physical activity, and emotional well‐being. PCI decreases angina and th...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2013-02, Vol.81 (2), p.243-259
Main Authors: Blankenship, James C., Marshall, J. Jeffrey, Pinto, Duane S., Lange, Richard A., Bates, Eric R., Holper, Elizabeth M., Grines, Cindy L., Chambers, Charles E.
Format: Article
Language:English
Subjects:
angina
Angina Pectoris - psychology
Angina Pectoris - therapy
Cardiovascular Agents - therapeutic use
Consensus
Coronary Artery Bypass
Emotions
Exercise Tolerance
Health Status
Humans
Mental Health
Myocardial Ischemia - physiopathology
Myocardial Ischemia - psychology
Myocardial Ischemia - therapy
Patient Selection
percutaneous coronary intervention
Percutaneous Coronary Intervention - standards
Quality of Life
stenting
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous coronary intervention (PCI) decreases ischemic complications of acute coronary syndromes. The benefits of PCI in stable ischemic heart disease (SIHD) depend on its effect on quality of life (QoL), including angina, physical activity, and emotional well‐being. PCI decreases angina and the need for anti‐anginal medications, and increases exercise capacity and QoL, compared with baseline status and compared with medical therapy without PCI. These benefits are greater when QOL is markedly impaired by severe angina before the procedure. When considering treatment options for symptomatic SIHD, physicians should consider and provide objective data regarding QoL effects for each treatment strategy. QoL outcomes should be considered in clinical trials, appropriate use criteria, practice guidelines, and reimbursement policies for PCI. © 2012 Wiley Periodicals, Inc.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.24376